Filing Details

Accession Number:
0001140361-17-033128
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-23 20:26:27
Reporting Period:
2017-08-21
Accepted Time:
2017-08-23 19:26:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1594337 Corium International Inc. CORI Pharmaceutical Preparations (2834) 383230774
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603700 Parminder Singh C/O Corium International, Inc.
235 Constituion Drive
Menlo Park CA 94025
Cto & Vice President, R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-21 7,593 $7.53 30,762 No 4 S Direct
Common Stock Disposition 2017-08-22 22,822 $7.61 7,940 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.89 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.